| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.83T | 1.78T | 1.63T | 1.61T | 1.27T |
| Gross Profit | 327.59B | 338.37B | 265.82B | 235.48B | 151.91B |
| EBITDA | 295.25B | 281.26B | 206.43B | 200.74B | 141.63B |
| Net Income | 213.26B | 425.49B | 261.65B | 796.06B | 708.82B |
Balance Sheet | |||||
| Total Assets | 5.96T | 4.98T | 4.12T | 3.56T | 2.69T |
| Cash, Cash Equivalents and Short-Term Investments | 209.82B | 163.29B | 120.29B | 94.46B | 100.88B |
| Total Debt | 2.48T | 1.82T | 1.30T | 1.15T | 1.00T |
| Total Liabilities | 3.03T | 2.26T | 1.75T | 1.63T | 1.35T |
| Stockholders Equity | 2.87T | 2.69T | 2.35T | 1.93T | 1.28T |
Cash Flow | |||||
| Free Cash Flow | -88.06B | -93.69B | -21.04B | 283.39B | 195.30B |
| Operating Cash Flow | 450.96B | 360.50B | 314.20B | 549.92B | 307.64B |
| Investing Cash Flow | -721.59B | -450.80B | -352.87B | -282.00B | -107.45B |
| Financing Cash Flow | 312.92B | 117.06B | 49.73B | -281.71B | -191.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥188.76B | 7.13 | 13.08% | 3.75% | -7.12% | 29.40% | |
72 Outperform | ¥1.55T | 12.54 | 11.32% | 5.12% | -2.82% | -54.04% | |
64 Neutral | ¥2.24T | 11.43 | 10.82% | 6.25% | -6.37% | -52.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥11.72B | 1,812.20 | ― | 5.77% | 8.37% | -87.14% | |
55 Neutral | ¥2.09T | 17.02 | 10.90% | 5.81% | 2.80% | -47.61% | |
54 Neutral | ¥159.55B | 12.04 | ― | 4.08% | -10.27% | -16.20% |